Marinus Pharmaceuticals

European Medicines Agency Grants Marinus Pharmaceuticals Accelerated Assessment of Ganaxolone for Treatment of CDKL5 Deficiency Disorder

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently granted its request for …

European Medicines Agency Grants Marinus Pharmaceuticals Accelerated Assessment of Ganaxolone for Treatment of CDKL5 Deficiency Disorder Read More


Ocugen

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate

MALVERN, PA — Ocugen, Inc., (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …

European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate Read More